Status:
COMPLETED
Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)
Lead Sponsor:
LifeScan
Conditions:
Diabetes
Eligibility:
All Genders
Phase:
NA
Brief Summary
Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential. We examined HbA1c changes using the OneTouch(R) Ul...
Eligibility Criteria
Inclusion
- Male or female subjects with type 1 or type 2 insulin-treated diabetes mellitus with a baseline HbA1c greater than or equal to 8.0%.
- The lower age limit for pediatric subjects was at the discretion of the pediatric investigators and their Institutional Review Board (IRBs).
- The upper age limit for pediatric subjects was 20 years (i.e., not having reached their 21st birthday on date of enrollment).
- Subjects must have monitored blood glucose at least 2 times per day. - Subject's current blood glucose meter has download capability, however, the subject did not routinely use this capability on his/her own.
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00333853
Start Date
August 1 2003
End Date
June 1 2005
Last Update
May 13 2008
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes and Endocrine Associates
La Jolla, California, United States, 92037
2
Children's Hospital, Los Angeles
Los Angeles, California, United States, 90027
3
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
4
University of Maryland School of Medicine
Baltimore, Maryland, United States, 21201